Efficacy and Safety of Intravenous Golimumab Through 1 Year in Patients With Active Psoriatic Arthritis

Arthritis Care and Research - United States
doi 10.1002/acr.23905
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Ustekinumab in Patients With Psoriasis and Psoriatic Arthritis

Clinical pharmacology and therapy
2018English

Inhibition of Radiographic Progression Across Levels of Composite Index-Defined Disease Activity in Patients With Active Psoriatic Arthritis Treated With Intravenous Golimumab: Results From a Phase-3, Double-Blind, Placebo-Controlled Trial

Arthritis Research & Therapy
2020English

PMS75 Annual Golimumab Utilization and Costs for Psoriatic Arthritis Patients Enrolled in Managed Care Plans

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

P146 Golimumab in Rheumatoid and Psoriatic Arthritis. The Relationship Between Minimum Serum Concentration, Anti-Golimumab Antibodies and Activity of Disease

2019English

Pss13 - Budget Impact Analysis of Apremilast in Patients With Active Psoriatic Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost Per Responder of Apremilast Versus Etanercept and Adalimumab in Patients With Active Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Erratum To: Analysis of Programmed Death-1 in Patients With Psoriatic Arthritis

Inflammation
AllergyImmunology
2015English

Peripheral Neuropathy in Patients With Psoriatic Arthritis

ScienceRise: Medical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy